Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nano-X Imaging Ltd. (NNOX : NSDQ)

• Company Description    NANO-X IMAGING LTD is a medical imaging technology company. NANO-X IMAGING LTD is based in Neve Ilan, Israel. Number of Employees: 165

• Price / Volume Information    Yesterday's Closing Price: $3.90 Daily Weekly Monthly 20 Day Moving Average: 1,122,930 shares Shares Outstanding: 57.78 (millions) Market Capitalization: $225.63 (millions) Beta: 1.94 52 Week High: $11.00 52 Week Low: $3.63 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.22% -14.75% 12 Week -22.67% -29.76% Year To Date -45.76% -50.77%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL OFER TECH PARK 94 SHLOMO SHMELTZER ROAD - PETACH TIKVA,L3 4970602 ISR ph: 9720337359202 fax: 972-02-544-5214 mike.cavanaugh@westwicke.com None

• General Corporate Information    Officers Erez Meltzer - Chief Executive Officer and Acting Chairman Ran Daniel - Chief Financial Officer Tamar Aharon Cohen - Executive Vice President and Chief Marketing Offic Noga Kainan - Director Dan Suesskind - Director Peer Information Nano-X Imaging Ltd. (EVOL) Nano-X Imaging Ltd. (RAMP) Nano-X Imaging Ltd. (LGTY) Nano-X Imaging Ltd. (ALOT) Nano-X Imaging Ltd. (CXT) Nano-X Imaging Ltd. (TGHI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: M70700105 SIC: 3844 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/20/25 Share - Related Items Shares Outstanding: 57.78 Most Recent Split Date: (:1) Beta: 1.94 Market Capitalization: $225.63 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.78 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/20/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.38 Price/Cash Flow: - Price / Sales: 18.98 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: -9.52% Sales Growth vs. Year Ago Period: 12.63% vs. Previous Quarter: 7.99% ROE 06/30/25 - -32.09 03/31/25 - -30.92 12/31/24 - -30.02 ROA 06/30/25 - -28.73 03/31/25 - -27.73 12/31/24 - -26.91 Current Ratio 06/30/25 - 4.19 03/31/25 - 5.30 12/31/24 - 5.63 Quick Ratio 06/30/25 - 4.03 03/31/25 - 5.16 12/31/24 - 5.52 Operating Margin 06/30/25 - -468.29 03/31/25 - -472.19 12/31/24 - -474.31 Net Margin 06/30/25 - -468.29 03/31/25 - -472.19 12/31/24 - -474.31 Pre-Tax Margin 06/30/25 - -469.91 03/31/25 - -475.22 12/31/24 - -477.48 Book Value 06/30/25 - 2.83 03/31/25 - 3.07 12/31/24 - 3.27 Inventory Turnover 06/30/25 - 14.64 03/31/25 - 17.70 12/31/24 - 13.61 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©